Up a level |
McClurg, Urszula L ORCID: 0000-0003-2631-4174, Nabbi, Arash, Ricordel, Charles, Korolchuk, Svitlana, McCracken, Stuart, Heer, Rakesh, Wilson, Laura, Butler, Lisa M, Irving-Hooper, Bronwyn Kate, Pedeux, Remy et al (show 3 more authors)
(2018)
Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein.
British Journal of Cancer, 118 (5).
pp. 713-726.
Nabbi, Arash, McClurg, Urszula L ORCID: 0000-0003-2631-4174, Thalappilly, Subhash, Almami, Amal, Mobahat, Mahsa, Bismar, Tarek A, Binda, Olivier and Riabowol, Karl T
(2017)
ING3 promotes prostate cancer growth by activating the androgen receptor.
BMC MEDICINE, 15 (1).
103-.
McClurg, Urszula L ORCID: 0000-0003-2631-4174, Chit, Nay CTH, Azizyan, Mahsa, Edwards, Joanne, Nabbi, Arash, Riabowol, Karl T, Nakjang, Sirintra, McCracken, Stuart R and Robson, Craig N
(2018)
Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12.
ONCOGENE, 37 (34).
pp. 4679-4691.
McClurg, Urszula L ORCID: 0000-0003-2631-4174, Harle, Victoria J, Nabbi, Arash, Batalha-Pereira, Amanda, Walker, Scott, Coffey, Kelly, Gaughan, Luke, McCracken, Stuart RC and Robson, Craig N
(2015)
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer.
ONCOTARGET, 6 (35).
pp. 37724-37736.